665 related articles for article (PubMed ID: 15176864)
1. Antibodies and genetically engineered related molecules: production and purification.
Roque AC; Lowe CR; Taipa MA
Biotechnol Prog; 2004; 20(3):639-54. PubMed ID: 15176864
[TBL] [Abstract][Full Text] [Related]
2. Tailor-made antibody therapeutics.
Chowdhury PS; Wu H
Methods; 2005 May; 36(1):11-24. PubMed ID: 15848071
[TBL] [Abstract][Full Text] [Related]
3. Affinity-based methodologies and ligands for antibody purification: advances and perspectives.
Roque AC; Silva CS; Taipa MA
J Chromatogr A; 2007 Aug; 1160(1-2):44-55. PubMed ID: 17618635
[TBL] [Abstract][Full Text] [Related]
4. Manufacturing of recombinant therapeutic proteins in microbial systems.
Graumann K; Premstaller A
Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
[TBL] [Abstract][Full Text] [Related]
5. Recent progress in biomolecular engineering.
Ryu DD; Nam DH
Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
[TBL] [Abstract][Full Text] [Related]
6. Engineered antibodies take center stage.
Huston JS; George AJ
Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic antibody production technologies: molecules, applications, expression and purification.
Humphreys DP; Glover DJ
Curr Opin Drug Discov Devel; 2001 Mar; 4(2):172-85. PubMed ID: 11378956
[TBL] [Abstract][Full Text] [Related]
8. Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology.
Huang C
Curr Opin Biotechnol; 2009 Dec; 20(6):692-9. PubMed ID: 19889530
[TBL] [Abstract][Full Text] [Related]
9. Implementation of advanced technologies in commercial monoclonal antibody production.
Zhou JX; Tressel T; Yang X; Seewoester T
Biotechnol J; 2008 Oct; 3(9-10):1185-200. PubMed ID: 18759247
[TBL] [Abstract][Full Text] [Related]
10. Development of humanized antibodies as cancer therapeutics.
Qu Z; Griffiths GL; Wegener WA; Chang CH; Govindan SV; Horak ID; Hansen HJ; Goldenberg DM
Methods; 2005 May; 36(1):84-95. PubMed ID: 15848077
[TBL] [Abstract][Full Text] [Related]
11. Design and manufacture of monoclonal antibodies for radioimmunotherapy.
Hale G; Berrie E; Bird P
Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):258-66. PubMed ID: 15640789
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of recombinant human anti-HAV monoclonal antibody.
Wei JS; Tao R; Sun WW; Jia Q; Li C; Liang MF
Sheng Wu Gong Cheng Xue Bao; 2004 Mar; 20(2):257-61. PubMed ID: 15969118
[TBL] [Abstract][Full Text] [Related]
13. Antibody purification by affinity chromatography based on small molecule affinity ligands identified by SPR-based screening of chemical microarrays.
Arnold M; Bittermann H; Kalbfuss-Zimmermann B; Neumann T; Schmidt K; Sekul R; Hilbrig F; Ludolph H; Freitag R
J Chromatogr A; 2011 Jul; 1218(29):4649-59. PubMed ID: 21683366
[TBL] [Abstract][Full Text] [Related]
14. The rapid discovery of engineered antibodies.
Wang M; He M
IDrugs; 2007 Aug; 10(8):562-5. PubMed ID: 17665332
[TBL] [Abstract][Full Text] [Related]
15. Glycosylation of antibody therapeutics: optimisation for purpose.
Jefferis R
Methods Mol Biol; 2009; 483():223-38. PubMed ID: 19183902
[TBL] [Abstract][Full Text] [Related]
16. Biopharmaceutical drug discovery using novel protein scaffolds.
Gill DS; Damle NK
Curr Opin Biotechnol; 2006 Dec; 17(6):653-8. PubMed ID: 17055245
[TBL] [Abstract][Full Text] [Related]
17. Antibody therapeutics, antibody engineering, and the merits of protein stability.
Demarest SJ; Glaser SM
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):675-87. PubMed ID: 18729019
[TBL] [Abstract][Full Text] [Related]
18. One-step affinity purification of recombinant urokinase-type plasminogen activator receptor using a synthetic peptide developed by combinatorial chemistry.
Jacobsen B; Gårdsvoll H; Juhl Funch G; Ostergaard S; Barkholt V; Ploug M
Protein Expr Purif; 2007 Apr; 52(2):286-96. PubMed ID: 17027282
[TBL] [Abstract][Full Text] [Related]
19. [Monoclonal antibodies and therapeutics].
Desgranges C
Pathol Biol (Paris); 2004 Jul; 52(6):351-64. PubMed ID: 15261379
[TBL] [Abstract][Full Text] [Related]
20. Molecular engineering and design of therapeutic antibodies.
Presta LG
Curr Opin Immunol; 2008 Aug; 20(4):460-70. PubMed ID: 18656541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
